Ocular Therapeutix (OCUL) Finished Goods (2014 - 2026)
Ocular Therapeutix (OCUL) reported Finished Goods of $2.45 million for Q2 2026, up 125.6% from $1.08 million a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Finished Goods (2014 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix posted Finished Goods of $1.64 million, up 22.7% from FY2024.
- Finished Goods has increased for four consecutive years, with a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- By year, Finished Goods came in at $1.34 million in FY2024 (+34.9%), $991,000 in FY2023 (+29.4%), $766,000 in FY2022 (+198.1%) and $257,000 in FY2021 (-56.1%).
- The Q2 2026 figure ranks as the highest quarterly Finished Goods in data going back to Q4 2014.
- Year over year, Finished Goods has now increased in each of the last four quarters, with growth averaging 44.4% over the last eight quarters.
- The high point for year-over-year Finished Goods in five years was Q4 2022 (growth of 198.1%); the low point was Q3 2021 (a decline of 61.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.21 million (Q1 2026), $1.64 million (Q4 2025) and $1.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.45 Mn |
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 809,000.00 |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 991,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 766,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | 513,000.00 |
| Mar 31, 2022 | 459,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Sep 30, 2021 | 289,000.00 |
API Access
Ocular Therapeutix Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();